AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. حسب Anthony L. Gaeta (13272609)

Decrease in vRNA in brain during antiretroviral therapy. حسب Sonny R. Elizaldi (9684796)

A mechanism of non-target site resistance conferred by loss-of-function of <i>PAM16</i> is conserved in <i>M</i>. <i>polymorpha</i>. حسب Chloe Casey (14341756)

Dcp1a protein levels are decreased by KapB expression and Torin treatment. حسب Carolyn-Ann Robinson (13297009)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

"…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"

ABT199 inhibits ALK ^mutant kinase activity and decreases it phosphorylation. حسب Richard Junior Zapata Dongo (17912565)

Dose-dependent decreases in cell viability with carboplatin, mitoxantrone, vinblastine, and CBD treatment of canine UC cells. حسب Jordon M. Inkol (11237604)

Performance of selected antimalarials against field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Primers used for analysis of four SNPs in one gene. حسب Winnie Okore (14139712)

الموضوعات:

Number of samples per site during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Performance of selected drugs against field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>Pfmrp1</i> gene SNPs data during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials. حسب Winnie Okore (14139712)

الموضوعات:

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. حسب Chi Chen (67021)

The S75A mutation of LeishIF4E3 leads to a decrease in granule formation in response to PBS starvation and to a reduced interaction with LeishIF4G-4. حسب Rohit Shrivastava (6459608)

Lower insular perfusion in the DAT group compared with the non-DAT group. حسب Masashi Takeuchi (1930312)

"…In the region of interest-based analysis, decrease extent ratios were higher in the DAT group (N = 12) than in the non-DAT group (N = 38) (D). …"

Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG حسب Meijuan Liu (4924417)

"…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…"

Image_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG حسب Meijuan Liu (4924417)

"…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…"